Literature DB >> 25854374

Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors.

Yeonju Kim1, Keun-Young Yoo, Marc T Goodman.   

Abstract

Although the incidence of breast cancer in Asia remains lower than in North America, Western Europe, and Oceania, rates have been increasing rapidly during the past few decades, and Asian countries now account for 40% of breast cancer cases diagnosed worldwide. Breast cancer mortality has also increased among Asian women, in contrast to decreased mortality in Northern America, Western Europe, and Oceania. These increased rates are associated with higher prevalence of breast cancer risk factors (e.g., reduced parity, delayed childbirth, increased obesity) that have accompanied economic development throughout the region. However, Asian regions (western, south-central, south-eastern, and eastern) and countries differ in the types and magnitude of changes in breast cancer risk factors, and cannot be viewed as a single homogeneous group. The objective of this paper was to contrast the heterogeneous epidemiology of breast cancer by Asian regions and countries, and to suggest potential avenues for future research.

Entities:  

Mesh:

Year:  2015        PMID: 25854374     DOI: 10.7314/apjcp.2015.16.7.2857

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  25 in total

1.  Response to Sung, Rosenberg, and Yang.

Authors:  Ching-Hung Lin; Yoon Sim Yap; Kyung-Hun Lee; Winnie Yeo; Takayuki Ueno; Huiping Li; Shu-Min Huang; Yen-Shen Lu
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

2.  68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study.

Authors:  Jie Zang; Feng Mao; Hao Wang; Jingjing Zhang; Qingxing Liu; Li Peng; Fang Li; Lixin Lang; Xiaoyuan Chen; Zhaohui Zhu
Journal:  Clin Nucl Med       Date:  2018-09       Impact factor: 7.794

3.  Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.

Authors:  P Riedlova; J Janoutova; B Hermanova
Journal:  Mol Biol Rep       Date:  2020-03-16       Impact factor: 2.316

4.  Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population.

Authors:  Jianqiu Tang; Qiaoxia Zhou; Fen Zhao; Fulin Wei; Jian Bai; Yuping Xie; Ying Huang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Incidence, mortality and survival of female breast cancer during 2003-2011 in Jiangsu province, China.

Authors:  Xinran Yan; Renqiang Han; Jinyi Zhou; Hao Yu; Jie Yang; Ming Wu
Journal:  Chin J Cancer Res       Date:  2016-06       Impact factor: 5.087

6.  Survival Rate of Breast Cancer in Iran: A Meta-Analysis

Authors:  Ghasem Abedi; Ghasem Janbabai; Mahmood Moosazadeh; Fereshte Farshidi; Mohammad Amiri; Ahmad Khosravi
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

7.  Female Breast Cancer Incidence and Mortality in Morocco: Comparison with Other Countries

Authors:  Mohamed Khalis; Karima El Rhazi; Hafida Charaka; Sabina Rinaldi; Chakib Nejjari; Isabelle Romieu; Barbara Charbotel
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

8.  Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients.

Authors:  Tzu-Ting Huang; Nicolas Pennarun; Yu-Hao Cheng; Cheng-Fang Horng; Jason Lei; Skye Hung-Chun Cheng
Journal:  Oncotarget       Date:  2018-05-01

9.  The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin.

Authors:  Dinesh Chandra Doval; Anurag Mehta; S P Somashekhar; Aparna Gunda; Gurpreet Singh; Amanjit Bal; Siddhant Khare; Chandra Prakash V Serkad; Manjula Adinarayan; Naveen Krishnamoorthy; Devanhalli Govinda Vijay; Radha Anantakrishnan; G S Bhattacharyya; Manjiri M Bakre
Journal:  Breast       Date:  2021-05-28       Impact factor: 4.380

10.  Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.

Authors:  Ali Arabkheradmand; Aghdas Safari; Mehri Seifoleslami; Emad Yahaghi; Masoumeh Gity
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.